ADMA Biologics: Lawsuit Application Deadline Set for August 10, 2026
Investors in ADMA Biologics, Inc. have a deadline of August 10, 2026, to submit applications for a class action securities lawsuit. Kahn Swick & Foti, LLC is notifying affected investors.
ADMA Biologics, Inc. is facing a class action securities lawsuit concerning investments made in the company's stock. The law firm Kahn Swick & Foti, LLC has issued a notice to investors regarding the proceedings and the upcoming deadline for participation.
The application deadline for investors to join the lawsuit or submit claims is August 10, 2026. The lawsuit alleges that investors suffered losses due to alleged misrepresentations or omissions made by the company regarding its business and operations. Such actions aim to aggregate claims from individuals who have experienced financial harm.
Kahn Swick & Foti, LLC, along with partner Charles C. Foti, Jr., is representing the investors in this legal matter. Investors who purchased ADMA Biologics securities during a specified class period and experienced financial damages are encouraged to contact the firm for further details on the process.
Class action lawsuits of this nature are common in the securities market when concerns arise about corporate disclosures. The objective is to provide a collective legal avenue for shareholders to seek recourse and potential compensation.